top of page


Retatrutide vs Semaglutide vs Tirzepatide: Which Is Better for Weight Loss in 2026?
A Quick Note Before You Begin In the span of just a few years, the medical weight loss landscape has been completely rewritten by a new class of medications. Semaglutide reset expectations in 2021. Tirzepatide pushed them further in 2022 and 2023. By late 2026, a third contender is reshaping the conversation again: retatrutide, a triple-agonist molecule with the most impressive early clinical data of any weight management medication to date. For patients considering medical w

Jan Medical Group
Oct 219 min read


Before You Start a Weight Loss Injection: 7 Questions to Ask Your Physician (That Most Clinics Skip)
A Note Before You Begin Weight loss injections have become one of the most searched health topics of the past three years, and for good reason. GLP-1 receptor agonists such as semaglutide and tirzepatide have delivered clinical results that were once considered impossible without surgery: 15 to 22 percent total body weight loss in randomised controlled trials, with meaningful improvements in blood sugar, blood pressure, and cardiovascular risk markers. The surge in demand has

Jan Medical Group
Jun 248 min read


Mounjaro vs Wegovy in the Philippines: Which GLP-1 Is Right for You?
Two medications now dominate the conversation around medical weight management in the Philippines: Mounjaro and Wegovy. Both are weekly injectable medications. Both produce clinically meaningful weight loss. Both have generated enormous interest among Filipino patients, and both have generated an equal amount of confusion about which is the better choice. The question of Mounjaro vs Wegovy Philippines is genuinely important because the two medications, while related, are not

Christian Espedido
May 129 min read
bottom of page
